亡细胞促进循环瘤细胞的存活和转移
Cassidy E Hagan1, Valerie M Sheehan1, Charles M Rezanka1
1Department of Immunology, University of Washington, Seattle, WA, USA.
Communications biology
|July 29, 2025
概括
死亡的细胞,特别是亡细胞,促进癌症转移. 这些细胞通过脂和组织因子招募血小板,形成凝块,保护肺部循环瘤细胞 (CTC).
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 细胞死亡在瘤进展和癌症治疗期间很常见.
- 死亡细胞在瘤转移中的作用尚未完全理解.
- 高水平的亡细胞与较差的患者结果相关.
研究的目的:
- 为了研究细胞亡对瘤进展的生理影响.
- 为了确定阿波细胞如何影响转移.
- 阐明细胞亡细胞促进转移的机制.
主要方法:
- 在小鼠的静脉转移模型.
- 在肺血管中分析循环瘤细胞 (CTC) 存活率.
- 研究血小板招募和血栓形成.
- 基因操纵 (组织因子的淘汰) 和药物抑制 (脂胺阻塞,肝素的管理).
主要成果:
- 亡细胞,但不是通过其他机制死亡的细胞,显著增强了肺转移.
- 异位细胞通过将血小板招募到转移性位来促进CTC的生存.
- 在亡细胞上外部化脂胺激活组织因子,导致形成血小板凝块,保护CTCs.
- 抑制凝血 (通过组织因子淘汰,酸胺阻塞或肝素) 废除了阿波细胞的转移前作用.
结论:
- 亡细胞在促进转移方面发挥了以前未知的作用.
- 亡细胞为循环中的瘤细胞建立保护性栓塞.
- 向细胞缩的前凝活动可能会减少转移.
更多相关视频
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
8.8K
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
9.4K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Phagocytosis of Apoptotic Cells
4.0K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
4.0K
Apoptosis
12.0K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
